U.S. market Closed. Opens in 11 hours 40 minutes

FBRX | Forte Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/AN/AN/A18.04M41.00K49.00K51.00K
Cost of Revenue9.00KN/A36.00K54.00K11.00KN/AN/AN/AN/A
Gross Profit-9.00KN/A-36.00K-54.00K-11.00K18.04MN/AN/AN/A
Operating Expenses32.48M13.90M21.49M14.22M4.06M63.89M37.67M31.69M23.00M
Selling, General & Admin10.62M8.30M7.63M4.22M1.38M12.81M8.56M4.52M3.83M
Research & Development21.86M5.59M13.85M10.00M2.68M51.08M29.11M27.22M19.17M
Other Operating ExpensesN/A17.00K-222.00K-205.00K-6.85KN/AN/A-50.00KN/A
Operating Income-32.49M-13.90M-21.49M17.83M-4.06M-45.85M-37.63M-31.64M-22.95M
Other Expenses / Income1.01M17.00K-222.00K-64.32M-4.33K-1.40M-1.30M-1.84M-102.00K
Before Tax Income-31.48M-13.88M-21.71M-46.49M-4.07M-47.26M-38.93M-33.48M-23.06M
Income Tax ExpensesN/A-17.00K-200.56K32.06M-2.52K1.70MN/AN/AN/A
Net Income-31.48M-13.86M-21.71M-78.54M-4.07M-48.95M-38.93M-33.48M-23.06M
Interest ExpensesN/A-17.00KN/AN/A-3.82M-1.40M-1.30M-1.84M-102.00K
Basic Shares Outstanding31.57M17.38M13.97M7.36M2.11M1.34M973.89K1.23M1.23M
Diluted Shares Outstanding31.57M17.38M13.97M7.36M2.11M1.34M973.89K1.23M1.23M
EBITDA-32.48M-13.90M-21.45M17.89M-4.05M-48.03M-39.94M-35.06M-22.93M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%-266.28%-97,407.32%-71,551.02%-44,952.94%
EBIT-31.48M-13.90M-21.91M-46.49M-7.89M-48.65M-40.23M-35.31M-23.16M
EBIT Margin0.00%0.00%0.00%0.00%0.00%-269.75%-98,119.51%-72,071.43%-45,407.84%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙